Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy (original) (raw)
References
Wapnick S, Jones JJ: Changes in glucose tolerance and serum insulin following partial gastrectomy and intestinal resection. Gut 13:871–873, 1972 Google Scholar
Lauritsen KB, Frederiksen HJ, Uhrenholdt A, Holst JJ: The correlation between gastric emptying time and the response of GIP and enteroglucagon to oral glucose in duodenal ulcer patients. Scand J Gastroenterol 17:513–516, 1982 Google Scholar
Sagor GR, Ghatei MA, McGregor GP, Mitchenere P, Kirk RM, Bloom SR: The influence of an intact pylorus on postprandial enteroglucagon and neurotensin release after upper gastric surgery. Br J Surg 68:190–193, 1981 Google Scholar
Jenkins DJA, Bloom SR, Albuquerque RH, Leeds AR, Sarson DL, Metz GL, Alberti KGMM: Pectin and complications after gastric surgery: normalisation of postprandial glucose and endocrine responses. Gut 21:574–579, 1980 Google Scholar
Bloom SR, Royston CMS, Thomson JPS: Enteroglucagon release in the dumping syndrome. Lancet 2:788–791, 1972 Google Scholar
Thomson JPS, Bloom SR: Plasma enteroglucagon and plasma volume change after gastric surgery. Clin Sci Mol Med 51:177–183, 1976 Google Scholar
Lawaetz O, Blackburn AM, Bloom SR, Aritas Y, Ralphs DNL: Gut hormone profile and gastric emptying in the dumping syndrome. Scand J Gastroenterol 18:73–80, 1983 Google Scholar
Bell GI, Sanchez-Pescador R, Laybourn PJ, Najarian RC: Exon duplication and divergence in the human preproglucagon gene. Nature 304:369–371, 1983 Google Scholar
Heinrich G, Gros P, Habener JF: Glucagon gene sequence four of six exons encode separate functional domains of rat preproglucagon. J Biol Chem 259:14082–14088, 1984 Google Scholar
Ørskov C, Holst JJ, Knuhtsen S, Baldissera FGA, Poulsen SS, Nielsen OV: Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. Endocrinology 119:1467–1475, 1986 Google Scholar
Holst JJ, Ørskov C, Nielsen OV, Schwartz TW: Truncated glucagonlike peptide-1, an insulin releasing hormone from the distal gut. FEBS Lett 211:169–174, 1987 Google Scholar
Mojsov S, Weir GC, Habener JF: Insulinotropin: Glucagon-like peptide-1 (7–37) encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 79:616–619, 1987 Google Scholar
Kreymann B, Ghatei MA, Williams G, Bloom SR: Glucagon-like peptide-1 (7–36): A physiological incretin in man. Lancet 2:1300–1305, 1987 Google Scholar
Sigstad H: A clinical diagnostic index in the diagnosis of the dumpings syndrome. Acta Med Scand 188:479–486, 1970 Google Scholar
Miholic J, Meyer HJ, Kotzerke J, Balks HJ, Aebert H, Jähne J, Pichlmayr R: Emptying of the gastric substitute after total gastrectomy: Roux-y esophagojejunostomy vs jejunal interposition. Ann Surg 210:39–46, 1989 Google Scholar
Ørskov C, Holst JJ: Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2). Scand J Clin Lab Invest 47:165–174, 1987 Google Scholar
Ørskov C, Holst JJ, Poulsen SS, Kirkegaard P: Pancreatic and intestinal processing of proglucagon in man. Diabetologia 30:874–881, 1987 Google Scholar
Holst JJ: Evidence that peak II GLI or enteroglucagon is identical to the C-terminal sequence (residues 33–69) of glicentin. Biochem J 207:381–388, 1982 Google Scholar
Bradley EL, Isaacs J, Harsh T, Davidson ED, Millikan W: Nutritional consequences of total gastrectomy. Ann Surg 182:415–429, 1975 Google Scholar
Huguier M, Lancret JM, Bernard PF, Baschet C, LeHenand F: Functional results of different reconstructive procedures after total gastrectomy. Br J Surg 63:704–708, 1976 Google Scholar
Miholic J, Meyer HJ, Müller MJ, Weimann A, Pichlmayr R: Nutritional consequences of total gastrectomy: the relationship between mode of reconstruction, postprandial symptoms and body composition. Surgery 108:488–494, 1990 Google Scholar
Hertz AF: The cause and treatment of some unfavorable after-effects of gastroenterostomy. Ann Surg 58:466–472, 1913 Google Scholar
Hobsley M: Dumping and diarrhoea. Br J Surg 68:681–684, 1981 Google Scholar
Roberts KE, Randall HT, Farr HW, Kidwell APP, McNeer GP, Pack GT: Cardiovascular and blood volume alterations resulting from intrajejunal administration of hypertonic solutions to gastrectomized patients: The relationship of these changes to the dumping syndrome. Ann Surg 140:631–640, 1954 Google Scholar
Peddie GH, Jordan GL, DeBakey ME: Further studies on the pathogenesis of the postgastrectomy syndrome. Ann Surg 146:892–898, 1957 Google Scholar
Holst JJ: Enteroglucagon. Adv Meta Disorders 11:393–419, 1988 Google Scholar
Thim L, Moody AJ: The primary structure of porcine glicentin (proglucagon). Regul Pept 2:139–151, 1981 Google Scholar
Baldissera FGA, Holst JJ: Glucagon-related peptides in the human gastrointestinal mucosa. Diabetologia 26:223–228, 1985 Google Scholar
Thim L, Moody AJ: Purification and biochemical characterization of glicentin-related pancreatic peptide (proglucagon fragment) from porcine pancreas. Biochim Biophys Acta 703:134–141, 1982 Google Scholar
Ørskov C, Bersani M, Johnsen AH, Højrup P, Holst JJ: Complete sequences of glucagon-like peptide-1 from human and pig small intestine. J Biol Chem 264:12826–12829, 1989 Google Scholar
Buhl T, Thim L, Kofod H, Ørskov C, Harling H, Holst JJ: Naturally occurring products of proglucagon 111–160 in the porcine and human small intestine. J Biol Chem 263:8621–8624, 1988 Google Scholar
Ørskov C, Buhl T, Rabenhøj L, Lofod H, Holst JJ: Carboxypeptidase-B like processing of the C-terminus of glucagon-like peptide-2 in pig and human small intestine. FEBS Lett 247:193–196, 1989 Google Scholar
Schjoldager BTG, Baldissera FGA, Mortensen PE, Holst JJ, Christiansen J: Oxyntomodulin: A potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid and insulin secretion in man. Eur J Clin Invest 18:499–503, 1988 Google Scholar
Jarrousse C, Bataille D, Jeanrenaud B: A pure enteroglucagon, oxyntomodulin (glucagon-37), stimulates insulin release in perfused rat pancreas. Endocrinology 115:102–105, 1984 Google Scholar
Holst JJ: Gut glucagon, enteroglucagon, gut GLI, glicentin-current status. Gastroenterology 84:1602–1613, 1983 Google Scholar
Marco J, Baroja IM, Diaz-Fierros M, Villanueva ML, Valverde I: Relationship between insulin and gut glucagon-like immunoreactivity (GLI) secretion in normal and gastrectomized subjects. J Clin Endocrinol 34:188–191, 1972 Google Scholar
Shima K, Kuruda K, Matsuyama T, Tarui S, Nishikawa M: Plasma glucagon and insulin responses to various sugars in gastrectomized and normal subjects. Proc Soc Exper Bio Med 139:1042–1048, 1971 Google Scholar
Rehfeld JF, Heding LG, Holst JJ: Increased gut glucagon release as pathogenic factor in reactive hypoglycemia? Lancet 1:116–118, 1973 Google Scholar
Shima S, Tabata M, Tanaka A, Kodaira T, Nishino T, Kumahara Y: Exaggerated response of plasma glucagon-like immunoreactivity (GLI) to oral glucose in patients with reactive hypoglycemia. Endocrinol Jpn 28:249–256, 1981 Google Scholar
Holst JJ, Sørensen TIA, Nyboe Anderson A, Andersen B, Stadil F, Lauritsen KB, Klein HC: Plasma enteroglucagon after jejuno-ileal bypass with 3 to 1 and 1 to 3 jejunoileal ratio. Scand J Gastroenterol 14:205–207, 1979 Google Scholar
Lauritsen KB, Moody AJ, Christensen KC, Jensen SL: Gastric inhibitory polypeptide (GIP) and insulin release after small-bowel resection in man. Scand J Gastroenterol 15:833–840, 1980 Google Scholar
Holst JJ: Pattern of glucagon release.In Gut Hormones. SR Bloom (ed). London, Churchill-Livingstone, 1981, pp 325–338 Google Scholar
Creutzfeldt W, Ebert R: New developments in the incretin concept. Diabetologie 28:565–573, 1985 Google Scholar
Nauck M, Schmidt WE, Ebert R, Strietzel J, Cantor P, Hoffmann G, Creutzfeldt W: Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: Interactions with glucose, phenylalanine, and cholecystokinin-8. J Clin Endo Metab 69:654–661, 1989 Google Scholar
Schattenmann G, Ebert R, Siewert R, Creutzfeldt W: Different response of gastric inhibitory polypeptide to glucose and fat from duodenum and jejunum. Scand J Gastroenterol 19:260–266, 1984 Google Scholar
Ørskov C, Holst JJ, Nielsen OV: Effect of truncated glucagon-like peptide-1 (proglucagon 78–107 amide) on endocrine secretion of pig pancreas, antrum, and nonantral stomach. Endocrinology 123:2009–2013, 1988 Google Scholar
Elahi D, Meneilly GS, Sclater A, Wong G, McAloon-Dyke, Mojsov S, Habener J, Minaker K, Andersen DK: The insulinotropic effect of GIP: A dose response comparison to glucagonlike peptide-1 (7–37) amine (GLP). Digestion 46:(S1):28, 1990 Google Scholar
Forbes GB: Human Body Composition. Growth, Aging, Nutrition and Activity. Springer-Verlag, New York, 1987, pp 178–193 Google Scholar
Cherrington AD, Liljenquist JE: Role of glucagon in regulating glucose production in vivo.In Glucagon Physiology, Pathophysiology and Morphology of the Pancreatic A-Cells. RH Unger, L Orci (eds). Amsterdam, Elsevier, 1981, pp 221–254 Google Scholar